BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alba J, Ishii Y, Thomson K, Moland ES, Yamaguchi K. Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 2005;49:4760-2. [PMID: 16251324 DOI: 10.1128/AAC.49.11.4760-4762.2005] [Cited by in Crossref: 52] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Hindiyeh M, Smollen G, Grossman Z, Ram D, Davidson Y, Mileguir F, Vax M, Ben David D, Tal I, Rahav G, Shamiss A, Mendelson E, Keller N. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J Clin Microbiol 2008;46:2879-83. [PMID: 18614657 DOI: 10.1128/JCM.00661-08] [Cited by in Crossref: 98] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
2 Shapiro AB. Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam. Antimicrob Agents Chemother 2017;61:e01612-17. [PMID: 28971872 DOI: 10.1128/AAC.01612-17] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 4.4] [Reference Citation Analysis]
3 Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections. Antimicrob Agents Chemother 2017;61:e02097-16. [PMID: 28031201 DOI: 10.1128/AAC.02097-16] [Cited by in Crossref: 177] [Cited by in F6Publishing: 142] [Article Influence: 35.4] [Reference Citation Analysis]
4 Gootz TD, Lescoe MK, Dib-Hajj F, Dougherty BA, He W, Della-Latta P, Huard RC. Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob Agents Chemother 2009;53:1998-2004. [PMID: 19258268 DOI: 10.1128/AAC.01355-08] [Cited by in Crossref: 113] [Cited by in F6Publishing: 77] [Article Influence: 8.7] [Reference Citation Analysis]
5 Abril D, Vergara E, Palacios D, Leal AL, Marquez-Ortiz RA, Madroñero J, Corredor Rozo ZL, De La Rosa Z, Nieto CA, Vanegas N, Cortés JA, Escobar-Perez J. Within patient genetic diversity of blaKPC harboring Klebsiella pneumoniae in a Colombian hospital and identification of a new NTEKPC platform. Sci Rep 2021;11:21409. [PMID: 34725422 DOI: 10.1038/s41598-021-00887-2] [Reference Citation Analysis]
6 Levitt PS, Papp-Wallace KM, Taracila MA, Hujer AM, Winkler ML, Smith KM, Xu Y, Harris ME, Bonomo RA. Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysis. J Biol Chem 2012;287:31783-93. [PMID: 22843686 DOI: 10.1074/jbc.M112.348540] [Cited by in Crossref: 50] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
7 Chen L, Mediavilla JR, Endimiani A, Rosenthal ME, Zhao Y, Bonomo RA, Kreiswirth BN. Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants. J Clin Microbiol 2011;49:579-85. [PMID: 21123529 DOI: 10.1128/JCM.01588-10] [Cited by in Crossref: 86] [Cited by in F6Publishing: 61] [Article Influence: 7.2] [Reference Citation Analysis]
8 Pournaras S, Kristo I, Vrioni G, Ikonomidis A, Poulou A, Petropoulou D, Tsakris A. Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae. J Clin Microbiol 2010;48:2601-4. [PMID: 20504985 DOI: 10.1128/JCM.02134-09] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
9 Roth AL, Kurpiel PM, Lister PD, Hanson ND. bla(KPC) RNA expression correlates with two transcriptional start sites but not always with gene copy number in four genera of Gram-negative pathogens. Antimicrob Agents Chemother 2011;55:3936-8. [PMID: 21576436 DOI: 10.1128/AAC.01509-10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
10 Li G, Wei Q, Wang Y, Du X, Zhao Y, Jiang X. Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China. Eur J Clin Microbiol Infect Dis 2011;30:575-80. [PMID: 21153909 DOI: 10.1007/s10096-010-1124-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
11 Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, Carey RB, Thompson A, Stocker S, Limbago B, Patel JB. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:2723-5. [PMID: 17581941 DOI: 10.1128/JCM.00015-07] [Cited by in Crossref: 231] [Cited by in F6Publishing: 121] [Article Influence: 15.4] [Reference Citation Analysis]
12 Hidalgo-Grass C, Warburg G, Temper V, Benenson S, Moses AE, Block C, Strahilevitz J. KPC-9, a novel carbapenemase from clinical specimens in Israel. Antimicrob Agents Chemother 2012;56:6057-9. [PMID: 22964247 DOI: 10.1128/AAC.01156-12] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
13 Swathi CH, Chikala R, Ratnakar KS, Sritharan V. A structural, epidemiological & genetic overview of Klebsiella pneumoniae carbapenemases (KPCs). Indian J Med Res 2016;144:21-31. [PMID: 27834322 DOI: 10.4103/0971-5916.193279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
14 Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007;20:440-58, table of contents. [PMID: 17630334 DOI: 10.1128/CMR.00001-07] [Cited by in Crossref: 1391] [Cited by in F6Publishing: 692] [Article Influence: 92.7] [Reference Citation Analysis]
15 Castanheira M, Mendes RE, Sader HS. Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying blaKPC Collected in U.S. Hospitals from 2012 to 2015. Antimicrob Agents Chemother 2017;61:e02369-16. [PMID: 28031200 DOI: 10.1128/AAC.02369-16] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 5.6] [Reference Citation Analysis]
16 Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012;25:682-707. [PMID: 23034326 DOI: 10.1128/CMR.05035-11] [Cited by in Crossref: 681] [Cited by in F6Publishing: 340] [Article Influence: 75.7] [Reference Citation Analysis]
17 Peter H, Berggrav K, Thomas P, Pfeifer Y, Witte W, Templeton K, Bachmann TT. Direct detection and genotyping of Klebsiella pneumoniae carbapenemases from urine by use of a new DNA microarray test. J Clin Microbiol 2012;50:3990-8. [PMID: 23035190 DOI: 10.1128/JCM.00990-12] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
18 Chen LF, Anderson DJ, Paterson DL. Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist 2012;5:133-41. [PMID: 23055754 DOI: 10.2147/IDR.S26613] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
19 Cole JM, Schuetz AN, Hill CE, Nolte FS. Development and evaluation of a real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase genes. J Clin Microbiol 2009;47:322-6. [PMID: 19036932 DOI: 10.1128/JCM.01550-08] [Cited by in Crossref: 57] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
20 Lamoureaux TL, Frase H, Antunes NT, Vakulenko SB. Antibiotic resistance and substrate profiles of the class A carbapenemase KPC-6. Antimicrob Agents Chemother 2012;56:6006-8. [PMID: 22908150 DOI: 10.1128/AAC.01338-12] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hendrickx APA, Landman F, de Haan A, Borst D, Witteveen S, van Santen-Verheuvel MG, van der Heide HGJ, Schouls LM; Dutch CPE surveillance Study Group. Plasmid diversity among genetically related Klebsiella pneumoniae blaKPC-2 and blaKPC-3 isolates collected in the Dutch national surveillance. Sci Rep 2020;10:16778. [PMID: 33033293 DOI: 10.1038/s41598-020-73440-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
22 Ke W, Bethel CR, Thomson JM, Bonomo RA, van den Akker F. Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases. Biochemistry 2007;46:5732-40. [PMID: 17441734 DOI: 10.1021/bi700300u] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
23 Mueller L, Masseron A, Prod'Hom G, Galperine T, Greub G, Poirel L, Nordmann P. Phenotypic, biochemical and genetic analysis of KPC-41, a KPC-3 variant conferring resistance to ceftazidime-avibactam and exhibiting reduced carbapenemase activity. Antimicrob Agents Chemother 2019:AAC. [PMID: 31527032 DOI: 10.1128/AAC.01111-19] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
24 Wolter DJ, Kurpiel PM, Woodford N, Palepou MF, Goering RV, Hanson ND. Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4. Antimicrob Agents Chemother 2009;53:557-62. [PMID: 19015357 DOI: 10.1128/AAC.00734-08] [Cited by in Crossref: 74] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
25 Dara JS, Chen L, Levi MH, Kreiswirth BN, Pellett Madan R. Microbiological and Genetic Characterization of Carbapenem-Resistant Klebsiella pneumoniae Isolated From Pediatric Patients. J Pediatric Infect Dis Soc 2014;3:e10-4. [PMID: 24567846 DOI: 10.1093/jpids/pit049] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
26 Shields RK, Clancy CJ, Hao B, Chen L, Press EG, Iovine NM, Kreiswirth BN, Nguyen MH. Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae. Antimicrob Agents Chemother 2015;59:5793-7. [PMID: 26169413 DOI: 10.1128/AAC.00548-15] [Cited by in Crossref: 78] [Cited by in F6Publishing: 42] [Article Influence: 11.1] [Reference Citation Analysis]
27 Lomovskaya O, Sun D, Rubio-Aparicio D, Nelson K, Tsivkovski R, Griffith DC, Dudley MN. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae. Antimicrob Agents Chemother 2017;61:e01443-17. [PMID: 28848018 DOI: 10.1128/AAC.01443-17] [Cited by in Crossref: 149] [Cited by in F6Publishing: 87] [Article Influence: 29.8] [Reference Citation Analysis]
28 Migliorini LB, de Sales RO, Koga PCM, Doi AM, Poehlein A, Toniolo AR, Menezes FG, Martino MDV, Gales AC, Brüggemann H, Severino P. Prevalence of blaKPC-2, blaKPC-3 and blaKPC-30-Carrying Plasmids in Klebsiella pneumoniae Isolated in a Brazilian Hospital. Pathogens 2021;10:332. [PMID: 33809215 DOI: 10.3390/pathogens10030332] [Reference Citation Analysis]
29 Karaiskos I, Lagou S, Pontikis K, Rapti V, Poulakou G. The "Old" and the "New" Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How. Front Public Health 2019;7:151. [PMID: 31245348 DOI: 10.3389/fpubh.2019.00151] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 24.3] [Reference Citation Analysis]
30 Lamoureaux TL, Vakulenko V, Toth M, Frase H, Vakulenko SB. A novel extended-spectrum β-lactamase, SGM-1, from an environmental isolate of Sphingobium sp. Antimicrob Agents Chemother 2013;57:3783-8. [PMID: 23716045 DOI: 10.1128/AAC.00808-13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]